Rabeb Dhouib Selected Research

Infections

1/2022	Access to highly specialized growth substrates and production of epithelial immunomodulatory metabolites determine survival of Haemophilus influenzae in human airway epithelial cells.
1/2021	The DmsABC Sulfoxide Reductase Supports Virulence in Non-typeable Haemophilus influenzae.
10/2020	Peptide Methionine Sulfoxide Reductase from Haemophilus influenzae Is Required for Protection against HOCl and Affects the Host Response to Infection.
1/2020	An in vitro Reconstructed Human Skin Equivalent Model to Study the Role of Skin Integration Around Percutaneous Devices Against Bacterial Infection.
1/2020	Haemophilus influenzae Glucose Catabolism Leading to Production of the Immunometabolite Acetate Has a Key Contribution to the Host Airway-Pathogen Interplay.
12/2019	Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms.
5/2019	Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin-dinitroxide conjugate.
1/2018	Inhibition of Diverse DsbA Enzymes in Multi-DsbA Encoding Pathogens.
1/2016	A Novel, Molybdenum-Containing Methionine Sulfoxide Reductase Supports Survival of Haemophilus influenzae in an In vivo Model of Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rabeb Dhouib Research Topics

Disease

9	Infections 01/2022 - 01/2016
4	Tuberculosis (Tuberculoses) 11/2012 - 12/2007
1	Salmonella Infections (Salmonellosis) 04/2021
1	Inflammation (Inflammations) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2015

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 05/2019
3	EnzymesIBA 01/2018 - 09/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2021 - 05/2019
2	Hypochlorous Acid (Hypochlorite)IBA 01/2021 - 10/2020
2	dimethyl sulfoxide reductase (DMSO reductase)IBA 01/2021 - 01/2015
2	methionine sulfoxide reductaseIBA 10/2020 - 01/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	NucleosidesIBA 01/2022
1	PentosesIBA 01/2022
1	GuanineIBA 01/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2021
1	Antimicrobial PeptidesIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	CarbonIBA 01/2020
1	FluoroquinolonesIBA 05/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	MolybdenumIBA 01/2016
1	arabinogalactanIBA 11/2012
1	lipoarabinomannan (LAM)IBA 11/2012
1	Monoacylglycerol LipasesIBA 09/2010
1	cutinaseIBA 06/2010
1	LipidsIBA 12/2007

Therapy/Procedure

2	Therapeutics 01/2020 - 12/2019
1	Catheters 05/2019